DaVita's stock leads S&P 500 decliners after Berkshire pares stake. Its soft guidance isn't helping.

Core Viewpoint - DaVita Inc.'s stock experienced a significant decline of 13.5% following Berkshire Hathaway's decision to reduce its stake in the kidney dialysis provider [1] Group 1: Stock Performance - DaVita's stock (DVA) is on track for its largest one-day selloff in a year and a half, marking a notable downturn in its recent performance [1] - The stock has fallen for three out of the past five days, indicating a troubling trend [1] - The last comparable decline occurred on October 11, 2023, when the stock closed down 16.9% [1]